The stress of spaceflight gives viruses a holiday from immune surveillance, putting future deep-space missions in jeopardy
Herpes viruses reactivate in more than half of crew aboard Space Shuttle and International Space Station missions, according to NASA research published in Frontiers in Microbiology. While only a small proportion develop symptoms, virus reactivation rates increase with spaceflight duration and could present a significant health risk on missions to Mars and beyond.
NASA’s rapid viral detection systems and ongoing treatment research are beginning to safeguard astronauts – and immunocompromised patients on Earth, too.
Herpes viruses reactivate in immunocompromised astronauts
“NASA astronauts endure weeks or even months exposed to microgravity and cosmic radiation – not to mention the extreme G forces of take-off and re-entry,” says senior author Dr. Satish K. Mehta of KBR Wyle at the Johnson Space Center. “This physical challenge is compounded by more familiar stressors like social separation, confinement and an altered sleep-wake cycle.”
To study the physiological impact of spaceflight, Mehta and colleagues analyze saliva, blood and urine samples collected from astronauts before, during and after spaceflight.
“During spaceflight there is a rise in secretion of stress hormones like cortisol and adrenaline, which are known to suppress the immune system. In keeping with this, we find that astronaut’s immune cells – particularly those that normally suppress and eliminate viruses – become less effective during spaceflight and sometimes for up to 60 days after.”
In the midst of this stress-induced amnesty on viral killing, dormant viruses reactivate and resurface.
“To date, 47 out of 89 (53%) astronauts on short space shuttle flights, and 14 out of 23 (61%) on longer ISS missions shed herpes viruses in their saliva or urine samples,” reports Mehta. “These frequencies – as well as the quantity – of viral shedding are markedly higher than in samples from before or after flight, or from matched healthy controls.”
Overall, four of the eight known human herpes viruses were detected. These include the varieties responsible for oral and genital herpes (HSV), chickenpox and shingles (VZV) – which remain lifelong in our nerve cells – as well as CMV and EBV, which take permanent but uneventful residence in our immune cells during childhood. CMV and EBV, are two viruses associated with causing different strains of mononucleosis or the “kissing disease”.
Deep-space exploration could depend on effective prevention and treatment
So far, this viral shedding is typically asymptomatic.
“Only six astronauts developed any symptoms due to viral reactivation,” says Mehta. “All were minor.”
However, continued virus shedding post flight could endanger immunocompromised or uninfected contacts on Earth, like newborns.
“Infectious VZV and CMV were shed in body fluids up to 30 days following return from the International Space Station.”
What’s more, as we prepare for human deep-space missions beyond the moon and Mars, the risk that herpes virus reactivation poses to astronauts and their contacts could become more crucial.
“The magnitude, frequency and duration of viral shedding all increase with length of spaceflight.”
Developing countermeasures to viral reactivation is essential to the success of these deep-space missions, argues Mehta.
“The ideal countermeasure is vaccination for astronauts – but this is so far available only against VZV.”
“Trials of other herpes virus vaccines show little promise, so our present focus is on developing targeted treatment regimens for individuals suffering the consequences of viral reactivation.
“This research has tremendous clinical relevance for patients on Earth too. Already, our spaceflight-developed technologies for rapid viral detection in saliva have been employed in clinics and hospitals around the world.”
Learn more: Dormant viruses activate during spaceflight — NASA investigates
The Latest on: Virus reactivation
[google_news title=”” keyword=”virus reactivation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Virus reactivation
- How to deal with chickenpox as an adult — it can get very dangerouson April 27, 2024 at 7:51 am
For us as adults to be at all likely to become infected with the chickenpox virus, some conditions must be met. We must be in the group of people who avoided infection in childhood, and secondly, we ...
- Brace for Impact: These Are the Best Disaster Movies of All Timeon April 26, 2024 at 8:59 am
Whether it's a natural disaster, disease, or asteroid hurtling through space straight towards Earth, these disaster movies will keep you entertained even through an apocalypse.
- Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024on April 25, 2024 at 1:00 am
These include pools for SARS-CoV-2, SARS-CoV-2 MHC-1 ("CD8"), Lyme Disease, Cytomegalovirus ("CMV"), Respiratory Syncytial Virus ("RSV") and Epstein-Barr ... improper functioning of T-Cells and ...
- San Antonio Animal Care Services warn owners of parvovirus uptick in dogson April 24, 2024 at 4:49 pm
Parvovirus is a highly contagious disease among dogs, that can be deadly. It's mostly seen in puppies or dogs that haven't been vaccinated.
- Shingles 101: What is it and what do you do if you have it?on April 17, 2024 at 2:54 am
Jen Lewis came down with shingles. She thought she was developing psoriasis, but as the rash spread and became super painful, Jen thought, well, maybe not, and called her doctor.
- ‘I wouldn’t wish it on anyone’: What to know and do about shingleson April 16, 2024 at 10:31 pm
Shingles is a painful condition that affects about 10,000 people in Ireland every year. Early recognition may help treatment, and there are calls for the vaccine to be offered for free ...
- 4 Years In, a Sobering Look at Long COVID Progresson April 16, 2024 at 3:06 am
Catecholamine testing, for example, is now commonly used to diagnose long COVID, particularly in those who have dysautonomia, a condition caused by dysfunction of the autonomic nervous system and ...
- Monica Bertagnolli: U.S. 'Ready' for Next Pandemic Threaton April 15, 2024 at 12:25 pm
In part two of this exclusive video interview, MedPage Today editor-in-chief Jeremy Faust, MD, talks with Monica Bertagnolli, MD, the 17th director of the National Institutes of Health (NIH), about ...
- Experts Reveal How To Get Rid of a Cold Sore + the TikTok Trend You Shouldn’t Tryon April 12, 2024 at 7:06 am
For immediate relief, consider topical anesthetics containing lidocaine or benzocaine, such as Orajel Instant Pain Relief for Cold Sore. They can be applied directly to the sore with a Q-tip up to ...
- Does Medicare Cover the Shingles Vaccine?on April 11, 2024 at 9:35 am
Shingrix shingles vaccine weakened immune systems Redness. Pain. Medicare Part D Swelling. Warmth or itching at the injection site. your Medicare Advantage plan Had the shingles virus. Received the ...
via Bing News